Insider Transactions in Q3 2023 at Cerevel Therapeutics Holdings, Inc. (CERE)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 07
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-94.87%
|
$1,200,000
$24.07 P/Share
|
Sep 07
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|
Aug 04
2023
|
Paul D. Burgess |
BUY
Open market or private purchase
|
Direct |
21,880
+50.0%
|
$481,360
$22.93 P/Share
|
Aug 03
2023
|
Ronald C Renaud Jr President & CEO |
BUY
Open market or private purchase
|
Indirect |
83,857
+50.0%
|
$1,928,711
$23.96 P/Share
|
Jul 11
2023
|
N Anthony Coles |
SELL
Open market or private sale
|
Direct |
50,000
-94.87%
|
$1,500,000
$30.03 P/Share
|
Jul 11
2023
|
N Anthony Coles |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.68%
|
$150,000
$3.5 P/Share
|